Eli Lilly Stock Week Ahead (Dec. 22–26, 2025): LLY Enters Holiday Week With Obesity-Drug Catalysts, Pricing Headlines, and Policy Risk
As of Sunday, December 21, 2025, Eli Lilly and Company (NYSE: LLY) heads into a holiday-shortened trading week near recent highs, after a busy stretch of headlines spanning next-generation obesity drugs, potentially accelerated FDA review timelines, price cuts aimed at widening access, and a fast-evolving U.S. drug-pricing agenda. The stock’s setup for the week ahead is straightforward: fundamentals and pipeline momentum remain the core bull case, while the key overhangs are pricing pressure, policy uncertainty, and headline-driven volatility typical of a late-December tape. Eli Lilly stock price check: where LLY stands heading into the week LLY last traded around $1,071